Stifel Nicolaus Begins Coverage on Oruka Therapeutics (NASDAQ:ORKA)
Stifel Nicolaus began coverage on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report released on Friday, MarketBeat.com reports. The brokerage issued a buy rating and a $49.00 target price on the stock. ORKA has been the subject of a number of other research reports. Wedbush initiated coverage on Oruka Therapeutics in a […]
More Stories
Siacoin Trading 0.3% Higher This Week (SC)
Siacoin (SC) traded 1% lower against the dollar during the 1-day period ending at 7:00 AM E.T. on October 15th....
Verge (XVG) Reaches Market Cap of $66.83 Million
Verge (XVG) traded 2.7% higher against the dollar during the 24 hour period ending at 7:00 AM Eastern on October...
pufETH Price Tops $2,646.70 on Top Exchanges (PUFETH)
pufETH (PUFETH) traded up 3.4% against the US dollar during the 24 hour period ending at 7:00 AM ET on...
Status Trading 1.5% Lower Over Last Week (SNT)
Status (SNT) traded 0.1% higher against the dollar during the 24 hour period ending at 7:00 AM E.T. on October...
Fifth Third Securities Inc. Sells 2,891 Shares of iShares Russell Mid-Cap ETF (NYSEARCA:IWR)
Fifth Third Securities Inc. trimmed its stake in iShares Russell Mid-Cap ETF (NYSEARCA:IWR – Free Report) by 3.4% in the...
Fifth Third Securities Inc. Has $11 Million Holdings in Vanguard Russell 1000 Value (NASDAQ:VONV)
Fifth Third Securities Inc. trimmed its position in shares of Vanguard Russell 1000 Value (NASDAQ:VONV – Free Report) by 4.3%...